Excellent work from past HF, current IC fellow, and upcoming co-attending Erin Flattery showing how advanced HF presence at a SNH can identify advanced therapy candidates and lead to excellent outcomes after LVAD and/or transplant in a very disadvantaged population.
Randal Goldberg
@RandyGoldbergMD
Heart failure and txp cardiologist at NYU Langone. Associate Director OHT. Director of HF Bellevue. Cardiac Sarcoidosis. Opinions are my own.
108 Following 216 Followers 68 Posts
Latest posts 5
Great to see support of each 9ther from our excellent fellows! @DHayesMD did a great job with this case and a patient with presumptive metastatic angiosarcoma now has no cardiac mass seen!
@DHayesMD presenting a case of cardiac sarcoid presenting as a large bi-atrial mass @RandyGoldbergMD @nyulangone #ACC25View quoted post on X
Come Join us! Variety of pathology, equity in advanced therapies, dual organs (H-K, H-Lu, H-Li), clinical research across the spectrum of disease, and a great team to work with!
Graduating from Cardiology this yr & still considering a career in Adv HF + Transplant? NYU has 1 open ACGME spot. Great diversity of pts, pathologies. Lots of shock, tMCS. High volume VAD + Txp. Dedicated faculty who love to mentor. Message or email: Jason.Katz@nyulangone.orgView quoted post on X
One of our amazing transplant recipients @AlisonConklin started a magazine to help patients with the many feelings that come with chronic illnesses and waiting on an organ, appropriately titled #BonusDays. Stories from recipients. Our txp support group loved it! Check it out!
Recently published REALM-DCM a phase 3 international study on a disease modifying treatment for LMNA cardiomyopathy. While a negative trial, shows the future of our field with therapies targeting specific mutations!
#GenesMatter #BenefitOfTesting
ahajournals.org/doi/epdf/10.11…
#GenesMatter #BenefitOfTesting
ahajournals.org/doi/epdf/10.11…